In this issue:
ALBI better than PALBI and MELD-Na for predicting liver failure after hepatectomy
AFP for predicting response to atezolizumab + bevacizumab in HCC
Prognostic factors of elderly HCC patients
Surgical resection vs. RFA for early recurrent HCC
Natural history and HCC risk in untreated indeterminate-phase chronic HBV infection
US racial/ethnic disparities in HCC incidence and mortality
Outcomes of patients with liver cancer and SARS-COV-2 infection
Impact of HCC aetiology on efficacy of SBRT for HCC
Please login below to download this issue (PDF)